Business Description
Sopharma Trading AD
ISIN : BG1100086070
Total Employee Number:
3,602Compare
Compare
Traded in other countries / regions
SFT.Bulgaria6YH.Germany IPO Date
2022-03-31Description
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 1.45 | |||||
Debt-to-EBITDA | 2.89 | |||||
Interest Coverage | 6.23 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.08 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.1 | |||||
3-Year EBITDA Growth Rate | 39.2 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year Book Growth Rate | 32.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 26.96 | |||||
9-Day RSI | 34.71 | |||||
14-Day RSI | 38.76 | |||||
3-1 Month Momentum % | -0.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.25 | |||||
Quick Ratio | 0.63 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 60.29 | |||||
Days Sales Outstanding | 39.8 | |||||
Days Payable | 47.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -41.6 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 13.03 | |||||
Operating Margin % | 3.41 | |||||
Net Margin % | 2.19 | |||||
EBITDA Margin % | 5.16 | |||||
FCF Margin % | 0.26 | |||||
OCF Margin % | 1.35 | |||||
ROE % | 23.91 | |||||
ROA % | 5.5 | |||||
ROIC % | 11.08 | |||||
3-Year ROIIC % | 18.8 | |||||
ROC (Joel Greenblatt) % | 18.63 | |||||
ROCE % | 21.69 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.76 | |||||
Forward PE Ratio | 5.36 | |||||
PE Ratio without NRI | 3.84 | |||||
Shiller PE Ratio | 8.29 | |||||
Price-to-Owner-Earnings | 2.28 | |||||
PEG Ratio | 0.13 | |||||
PS Ratio | 0.08 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 1.04 | |||||
Price-to-Free-Cash-Flow | 31.32 | |||||
Price-to-Operating-Cash-Flow | 6.09 | |||||
EV-to-EBIT | 7.1 | |||||
EV-to-EBITDA | 4.41 | |||||
EV-to-Forward-EBITDA | 4.33 | |||||
EV-to-Revenue | 0.23 | |||||
EV-to-Forward-Revenue | 0.23 | |||||
EV-to-FCF | 87.94 | |||||
Price-to-GF-Value | 0.37 | |||||
Price-to-DCF (Earnings Based) | 0.14 | |||||
Price-to-DCF (FCF Based) | 2.62 | |||||
Price-to-Median-PS-Value | 0.27 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.15 | |||||
Price-to-Graham-Number | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 12.95 | |||||
Earnings Yield (Greenblatt) % | 14.08 | |||||
FCF Yield % | 3.11 | |||||
Forward Rate of Return (Yacktman) % | 9.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sopharma Trading AD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,178.3 | ||
| EPS (TTM) (€) | 0.749 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 38.76 | ||
| 14-Day ATR (€) | 0.026313 | ||
| 20-Day SMA (€) | 2.782 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 2.72 - 3.54 | ||
| Shares Outstanding (Mil) | 34.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sopharma Trading AD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sopharma Trading AD Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sopharma Trading AD Frequently Asked Questions
What is Sopharma Trading AD(FRA:6YH)'s stock price today?
The current price of FRA:6YH is €2.72. The 52 week high of FRA:6YH is €3.54 and 52 week low is €2.72.
When is next earnings date of Sopharma Trading AD(FRA:6YH)?
The next earnings date of Sopharma Trading AD(FRA:6YH) is .
Does Sopharma Trading AD(FRA:6YH) pay dividends? If so, how much?
Sopharma Trading AD(FRA:6YH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sopharma Trading AD
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers